The landscape of dementia prognosis has advanced dramatically with the arrival of advanced biomarkers, including amyloid PET scans, tau imaging, and blood-primarily based exams that will detect Alzheimer's pathology a long time just before signs and symptoms emerge. While these technological innovations characterize impressive progress in being familiar with neurodegenerative https://nicku742qal2.wikilowdown.com/user